Cargando…
Advances and Prospects in Vaccine Development against Enterococci
Enterococci are the second most common Gram-positive pathogen responsible for nosocomial infections. Due to the limited number of new antibiotics that reach the medical practice and the resistance of enterococci to the current antibiotic options, passive and active immunotherapies have emerged as a...
Autores principales: | Kalfopoulou, Ermioni, Huebner, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692742/ https://www.ncbi.nlm.nih.gov/pubmed/33147722 http://dx.doi.org/10.3390/cells9112397 |
Ejemplares similares
-
Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci
por: Kalfopoulou, Ermioni, et al.
Publicado: (2019) -
Immunochemical characterization of polysaccharide antigens from six clinical strains of Enterococci
por: Hsu, Carolyn T, et al.
Publicado: (2006) -
Generation of glucosylated sn-1-glycerolphosphate teichoic acids: glycerol stereochemistry affects synthesis and antibody interaction
por: Berni, Francesca, et al.
Publicado: (2020) -
Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage
por: Romero-Saavedra, F, et al.
Publicado: (2019) -
Synergy of the Bacteriocin AS-48 and Antibiotics against Uropathogenic Enterococci
por: Montalbán-López, Manuel, et al.
Publicado: (2020)